Morgan Stanley’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.8M Buy
1,163,339
+213,905
+23% +$10.4M ﹤0.01% 1806
2025
Q1
$48.4M Sell
949,434
-124,383
-12% -$6.34M ﹤0.01% 1850
2024
Q4
$48.5M Sell
1,073,817
-84,237
-7% -$3.8M ﹤0.01% 1861
2024
Q3
$43M Sell
1,158,054
-358,703
-24% -$13.3M ﹤0.01% 1976
2024
Q2
$46.4M Sell
1,516,757
-546,284
-26% -$16.7M ﹤0.01% 1833
2024
Q1
$60M Sell
2,063,041
-429,477
-17% -$12.5M ﹤0.01% 1594
2023
Q4
$68.7M Buy
2,492,518
+2,056,778
+472% +$56.7M ﹤0.01% 2119
2023
Q3
$9.76M Buy
435,740
+54,664
+14% +$1.23M ﹤0.01% 3148
2023
Q2
$15.5M Buy
381,076
+155,186
+69% +$6.31M ﹤0.01% 2732
2023
Q1
$10.9M Sell
225,890
-71,775
-24% -$3.48M ﹤0.01% 3058
2022
Q4
$11.4M Buy
297,665
+13,416
+5% +$512K ﹤0.01% 2949
2022
Q3
$14.3M Sell
284,249
-140,138
-33% -$7.04M ﹤0.01% 2581
2022
Q2
$17M Buy
424,387
+80,853
+24% +$3.24M ﹤0.01% 2462
2022
Q1
$12.8M Buy
343,534
+127,819
+59% +$4.77M ﹤0.01% 2607
2021
Q4
$8.59M Buy
215,715
+173,765
+414% +$6.92M ﹤0.01% 3113
2021
Q3
$1.56M Sell
41,950
-137,531
-77% -$5.12M ﹤0.01% 4764
2021
Q2
$7.59M Buy
179,481
+160,778
+860% +$6.8M ﹤0.01% 3312
2021
Q1
$885K Sell
18,703
-33,173
-64% -$1.57M ﹤0.01% 4808
2020
Q4
$3.17M Buy
51,876
+32,022
+161% +$1.95M ﹤0.01% 3757
2020
Q3
$927K Sell
19,854
-8,484
-30% -$396K ﹤0.01% 4260
2020
Q2
$1.44M Sell
28,338
-57,534
-67% -$2.92M ﹤0.01% 3883
2020
Q1
$3.83M Sell
85,872
-191,059
-69% -$8.52M ﹤0.01% 2709
2019
Q4
$13.3M Buy
276,931
+216,665
+360% +$10.4M ﹤0.01% 2089
2019
Q3
$2.04M Buy
60,266
+20,336
+51% +$688K ﹤0.01% 3773
2019
Q2
$1.8M Buy
39,930
+14,919
+60% +$671K ﹤0.01% 3854
2019
Q1
$942K Sell
25,011
-74,126
-75% -$2.79M ﹤0.01% 4154
2018
Q4
$3.4M Sell
99,137
-72,309
-42% -$2.48M ﹤0.01% 3310
2018
Q3
$8.06M Sell
171,446
-403,743
-70% -$19M ﹤0.01% 2647
2018
Q2
$19.4M Sell
575,189
-36,533
-6% -$1.23M 0.01% 1673
2018
Q1
$16.6M Buy
611,722
+478,675
+360% +$13M ﹤0.01% 1844
2017
Q4
$2.22M Buy
133,047
+29,357
+28% +$490K ﹤0.01% 3943
2017
Q3
$2.08M Sell
103,690
-473,167
-82% -$9.47M ﹤0.01% 3845
2017
Q2
$10.6M Buy
576,857
+501,534
+666% +$9.19M ﹤0.01% 2130
2017
Q1
$742K Sell
75,323
-219,780
-74% -$2.17M ﹤0.01% 4592
2016
Q4
$3.22M Buy
295,103
+263,510
+834% +$2.87M ﹤0.01% 3441
2016
Q3
$442K Buy
31,593
+10,085
+47% +$141K ﹤0.01% 4597
2016
Q2
$151K Buy
21,508
+10,419
+94% +$73.1K ﹤0.01% 5063
2016
Q1
$72K Buy
11,089
+5,578
+101% +$36.2K ﹤0.01% 5460
2015
Q4
$178K Sell
5,511
-59,862
-92% -$1.93M ﹤0.01% 5146
2015
Q3
$1.75M Buy
65,373
+35,027
+115% +$936K ﹤0.01% 3639
2015
Q2
$1.46M Buy
30,346
+16,116
+113% +$776K ﹤0.01% 3911
2015
Q1
$866K Sell
14,230
-2,899
-17% -$176K ﹤0.01% 4238
2014
Q4
$887K Buy
17,129
+5,791
+51% +$300K ﹤0.01% 4244
2014
Q3
$499K Sell
11,338
-5,079
-31% -$224K ﹤0.01% 4574
2014
Q2
$430K Buy
16,417
+3,763
+30% +$98.6K ﹤0.01% 4693
2014
Q1
$331K Buy
12,654
+5,960
+89% +$156K ﹤0.01% 4832
2013
Q4
$114K Buy
+6,694
New +$114K ﹤0.01% 5307